Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution
Authors:
- Koushi HidakaKHKoushi Hidaka
- Tsuyoshi UemuraTUTsuyoshi Uemura
- Keisuke KashimotoKKKeisuke Kashimoto
- Yuto HoriYHYuto Hori
- Yuko KawasakiYKYuko Kawasaki
- Adam J. RubenARAdam J. Ruben
- Ernesto FreireEFErnesto Freire
- Tooru KimuraTKTooru Kimura
- Yoshiaki KisoYKYoshiaki Kiso
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (16) , 4836-4839
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsinBioorganic & Medicinal Chemistry, 2008
- Search for substrate‐based inhibitors fitting the S2′ space of malarial aspartic protease plasmepsin IIJournal of Peptide Science, 2004
- High-Affinity Inhibition of a Family of Plasmodium falciparum Proteases by a Designed Adaptive InhibitorBiochemistry, 2003
- Medical need, scientific opportunity and the drive for antimalarial drugsNature, 2002
- Identification and Characterization of Allophenylnorstatine-Based Inhibitors of Plasmepsin II, an Antimalarial TargetBiochemistry, 2002
- Four plasmepsins are active in thePlasmodium falciparumfood vacuole, including a protease with an active-site histidineProceedings of the National Academy of Sciences, 2002
- Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targetsTrends in Parasitology, 2001
- Antimalarial Synergy of Cysteine and Aspartic Protease InhibitorsAntimicrobial Agents and Chemotherapy, 1998
- Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostereBiopolymers, 1996